Mosaic ImmunoEngineering Inc. Quarterly Common Stock, Shares Authorized from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Mosaic ImmunoEngineering Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q2 2011 to Q3 2024.
  • Mosaic ImmunoEngineering Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 100M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 100M 0 0% Sep 30, 2024 10-Q 2024-11-19
Q2 2024 100M 0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 100M 0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 100M 0 0% Dec 31, 2023 10-Q 2024-11-19
Q3 2023 100M 0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 100M 0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 100M 0 0% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 100M 0 0% Dec 31, 2022 10-K 2024-04-15
Q3 2022 100M 0 0% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 100M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 100M 0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 100M 0 0% Dec 31, 2021 10-K 2023-03-02
Q3 2021 100M -500M -83.3% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 100M 0 0% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 100M -500M -83.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 100M -500M -83.3% Dec 31, 2020 10-K 2022-01-26
Q3 2020 600M 0 0% Aug 31, 2020 10-Q 2020-10-15
Q2 2020 100M -500M -83.3% May 31, 2020 10-KT 2021-03-02
Q1 2020 600M 0 0% Feb 29, 2020 10-Q 2020-04-08
Q4 2019 600M 0 0% Nov 30, 2019 10-Q 2020-01-14
Q3 2019 600M 0 0% Aug 31, 2019 10-Q 2019-10-11
Q2 2019 600M 0 0% May 31, 2019 10-K 2020-08-24
Q1 2019 600M 0 0% Feb 28, 2019 10-Q 2019-04-15
Q4 2018 600M 0 0% Nov 30, 2018 10-Q 2019-01-14
Q3 2018 600M 0 0% Aug 31, 2018 10-Q 2018-10-15
Q2 2018 600M 0 0% May 31, 2018 10-K 2019-08-29
Q1 2018 600M 0 0% Feb 28, 2018 10-Q 2018-04-16
Q4 2017 600M 0 0% Nov 30, 2017 10-Q 2018-01-16
Q3 2017 600M 0 0% Aug 31, 2017 10-Q 2017-10-16
Q2 2017 600M 0 0% May 31, 2017 10-K 2018-08-29
Q1 2017 600M 0 0% Feb 28, 2017 10-Q 2017-04-13
Q4 2016 600M 0 0% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 600M 0 0% Aug 31, 2016 10-Q 2016-10-17
Q2 2016 600M 0 0% May 31, 2016 10-K 2017-08-29
Q1 2016 600M 0 0% Feb 29, 2016 10-Q 2016-04-14
Q4 2015 600M 0 0% Nov 30, 2015 10-Q 2016-01-14
Q3 2015 600M 0 0% Aug 31, 2015 10-Q 2015-10-15
Q2 2015 600M 0 0% May 31, 2015 10-K 2016-08-29
Q1 2015 600M 0 0% Feb 28, 2015 10-Q 2015-04-14
Q4 2014 600M 0 0% Nov 30, 2014 10-Q 2015-01-14
Q3 2014 600M 0 0% Aug 31, 2014 10-Q 2014-10-15
Q2 2014 600M 0 0% May 31, 2014 10-K 2015-08-31
Q1 2014 600M 0 0% Feb 28, 2014 10-Q 2014-04-14
Q4 2013 600M 0 0% Nov 30, 2013 10-Q 2014-01-14
Q3 2013 600M 0 0% Aug 31, 2013 10-Q 2013-10-15
Q2 2013 600M 0 0% May 31, 2013 10-K 2014-08-19
Q1 2013 600M 0 0% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 600M 0 0% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 600M 0 0% Aug 31, 2012 10-Q 2012-10-15
Q2 2012 600M 0 0% May 31, 2012 10-K 2013-08-23
Q1 2012 600M Feb 29, 2012 10-Q 2012-04-16
Q4 2011 600M Nov 30, 2011 10-Q 2012-01-17
Q3 2011 600M Aug 31, 2011 10-Q 2011-10-17
Q2 2011 600M May 31, 2011 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.